2024-Tandaric et al-preprint

[mleipold]

"Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti-CD73/anti-PD-L1 immunotherapy in Arm A of the NSGO-OV-UMB1/ENGOT-OV30 trial"
Luka Tandaric, Annika Auranen, Katrin Kleinmanns, René dePont Christensen, Liv Cecilie Vestrheim Thomsen, Cara Ellen Wogsland, Emmet Mc Cormack, Johanna Mäenpää, Kristine Madsen, Karen Stampe Petersson, Mansoor Raza Mirza, Line Bjørge
medRxiv, posted October 03, 2024
https://doi.org/10.1101/2024.10.02.24314755

- will update when/if this is peer-reviewed and published

- no dataset accession given

[LukaTandaric]

The paper has been published: https://febs.onlinelibrary.wiley.com/do ... 0261.13811

Unfortunately, the raw data is unable to be uploaded due to ethical regulations. However, the published version has extensive supplementary data.

[mleipold]

Thanks Luka.

For reference, even if the data cannot be fully released in a public database, is there a process for interested researchers to apply for access?